Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal gene transfer.

Simon N Waddington1, Suzanne Mk Buckley, Anna L David

  • 1University College London, Department of Haematology, Haemophilia Centre and Haemostasis Unit, Royal Free and University College London Medical School, Rowland Hill Street, London, NW3 2PF, UK. s.waddington@medsch.ucl.ac.uk

Current Opinion in Molecular Therapeutics
|October 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026
Same author

Metabolic expenditure, neurodevelopment, and weight gain into early childhood after fetal growth restriction.

Scientific reports·2026
Same author

Placental apelin expression is low in early-onset fetal growth restriction but there is no association between maternal circulating apelin and pregnancy outcome.

Placenta·2026
Same author

Surgeons' Perceptions on the Utility of a Conceptual Novel Force Sensor at the Surgeon-Tool Interface: Formative Interview Study.

JMIR formative research·2026
Same author

Rethinking urinary tract infections in women with abdominal pain in pregnancy: a prospective case-control study.

BMC pregnancy and childbirth·2026
Same author

A deep learning algorithm for automatic 3D segmentation and classification of the sheep placenta in magnetic resonance images.

Physiological reports·2026
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Fetal gene transfer offers a promising approach for treating genetic diseases early, potentially preventing irreversible damage and establishing immune tolerance. Recent studies demonstrate long-term correction of monogenetic disorders through this innovative therapeutic strategy.

Area of Science:

  • Developmental Biology
  • Gene Therapy
  • Medical Genetics

Background:

  • Gene transfer during early development presents unique advantages over intervention in mature individuals.
  • Potential benefits include preventing irreversible pathological changes and achieving immunological tolerance to therapeutic proteins.
  • Early intervention allows for higher vector-to-cell ratios and access to crucial stem cell/progenitor populations.

Purpose of the Study:

  • To provide a comprehensive summary of recent advancements in fetal gene transfer.
  • To review the development and application of new vector systems for fetal gene therapy.
  • To assess the potential and challenges of treating various diseases via fetal gene transfer.

Main Methods:

  • Review of published studies on fetal gene transfer for monogenetic disorders.

Related Experiment Videos

  • Analysis of research on novel vector systems and therapeutic transgenes.
  • Examination of studies evaluating fetal gene transfer in different organs (brain, lung, skin).
  • Assessment of safety and hazard data associated with fetal gene therapy.

    • Main Results:

    • Five studies have demonstrated long-term correction of monogenetic disorders using fetal gene transfer.
    • Various vector systems and therapeutic transgenes have been tested for efficacy.
    • Potential applications in treating diseases affecting the brain, lung, and skin have been explored.
    • Research has also focused on understanding the potential hazards of fetal gene therapy.

    Conclusions:

    • Fetal gene transfer is a rapidly developing field with significant potential for treating genetic diseases.
    • Early developmental intervention can overcome limitations associated with treating mature individuals.
    • Continued research into vector systems, therapeutic targets, and safety is crucial for clinical translation.